 | • レポートコード：D0804-13103 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、治療用ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。治療用ワクチンの種類別市場規模（ペプチド治療ワクチン、細胞治療ワクチン、核酸治療ワクチン）、用途別市場規模（腫瘍治療、B型肝炎、結核、単純ヘルペスウイルス、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Northeast Biotherapeutics、CIMAB S.A、Agenus、AVAX Technologies、Vaccinogen Inc、Corixa、Dendreon ・地域別グローバル市場分析 2015年-2020年 ・治療用ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・治療用ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・治療用ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・治療用ワクチンの南米市場（ブラジル、アルゼンチン） ・治療用ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ペプチド治療ワクチン、細胞治療ワクチン、核酸治療ワクチン ・用途別分析：腫瘍治療、B型肝炎、結核、単純ヘルペスウイルス、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Therapeutic Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Therapeutic Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Therapeutic Vaccines market has been segmented into
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine
By Application, Therapeutic Vaccines has been segmented into:
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Therapeutic Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Therapeutic Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Therapeutic Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Therapeutic Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Therapeutic Vaccines Market Share Analysis
Therapeutic Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Therapeutic Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Therapeutic Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Therapeutic Vaccines are:
Northeast Biotherapeutics
CIMAB S.A
Agenus
AVAX Technologies
Vaccinogen Inc
Corixa
Dendreon
Among other players domestic and global, Therapeutic Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Vaccines, with price, sales, revenue and global market share of Therapeutic Vaccines in 2018 and 2019.
Chapter 3, the Therapeutic Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Therapeutic Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Therapeutic Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Therapeutic Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Peptide Therapeutic Vaccine
1.2.3 Cell Therapeutic Vaccine
1.2.4 Nucleic Acid Therapeutic Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncotherapy
1.3.3 Hepatitis B
1.3.4 Tuberculosis
1.3.5 Herpes Simplex Virus
1.3.6 Others
1.4 Overview of Global Therapeutic Vaccines Market
1.4.1 Global Therapeutic Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Northeast Biotherapeutics
2.1.1 Northeast Biotherapeutics Details
2.1.2 Northeast Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Northeast Biotherapeutics SWOT Analysis
2.1.4 Northeast Biotherapeutics Product and Services
2.1.5 Northeast Biotherapeutics Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CIMAB S.A
2.2.1 CIMAB S.A Details
2.2.2 CIMAB S.A Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CIMAB S.A SWOT Analysis
2.2.4 CIMAB S.A Product and Services
2.2.5 CIMAB S.A Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Agenus
2.3.1 Agenus Details
2.3.2 Agenus Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Agenus SWOT Analysis
2.3.4 Agenus Product and Services
2.3.5 Agenus Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AVAX Technologies
2.4.1 AVAX Technologies Details
2.4.2 AVAX Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AVAX Technologies SWOT Analysis
2.4.4 AVAX Technologies Product and Services
2.4.5 AVAX Technologies Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Vaccinogen Inc
2.5.1 Vaccinogen Inc Details
2.5.2 Vaccinogen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Vaccinogen Inc SWOT Analysis
2.5.4 Vaccinogen Inc Product and Services
2.5.5 Vaccinogen Inc Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Corixa
2.6.1 Corixa Details
2.6.2 Corixa Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Corixa SWOT Analysis
2.6.4 Corixa Product and Services
2.6.5 Corixa Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dendreon
2.7.1 Dendreon Details
2.7.2 Dendreon Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dendreon SWOT Analysis
2.7.4 Dendreon Product and Services
2.7.5 Dendreon Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Therapeutic Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Therapeutic Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Therapeutic Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Therapeutic Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Therapeutic Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Therapeutic Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Therapeutic Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Therapeutic Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Therapeutic Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Therapeutic Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Therapeutic Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Therapeutic Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Therapeutic Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Therapeutic Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Therapeutic Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Therapeutic Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Therapeutic Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Therapeutic Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Therapeutic Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Therapeutic Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Therapeutic Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Therapeutic Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Therapeutic Vaccines Sales and Growth Rate (2015-2020)
6.4 France Therapeutic Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Therapeutic Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Therapeutic Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Therapeutic Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Therapeutic Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Therapeutic Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Therapeutic Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Therapeutic Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Therapeutic Vaccines Sales and Growth Rate (2015-2020)
7.5 India Therapeutic Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Therapeutic Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Therapeutic Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Therapeutic Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Therapeutic Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Therapeutic Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Therapeutic Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Therapeutic Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Therapeutic Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Therapeutic Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Therapeutic Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Therapeutic Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Therapeutic Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Therapeutic Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Therapeutic Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Therapeutic Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Therapeutic Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Therapeutic Vaccines Price by Type (2015-2020)
11 Global Therapeutic Vaccines Market Segment by Application
11.1 Global Therapeutic Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Therapeutic Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Therapeutic Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Therapeutic Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Therapeutic Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Therapeutic Vaccines Market Forecast (2021-2025)
12.2.2 Europe Therapeutic Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Therapeutic Vaccines Market Forecast (2021-2025)
12.2.4 South America Therapeutic Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Therapeutic Vaccines Market Forecast (2021-2025)
12.3 Therapeutic Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Therapeutic Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Therapeutic Vaccines Market Share Forecast by Type (2021-2025)
12.4 Therapeutic Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Therapeutic Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Therapeutic Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Therapeutic Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Therapeutic Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Therapeutic Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Northeast Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Northeast Biotherapeutics Therapeutic Vaccines Major Business
Table 9. Northeast Biotherapeutics Therapeutic Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. Northeast Biotherapeutics SWOT Analysis
Table 11. Northeast Biotherapeutics Therapeutic Vaccines Product and Services
Table 12. Northeast Biotherapeutics Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. CIMAB S.A Basic Information, Manufacturing Base and Competitors
Table 14. CIMAB S.A Therapeutic Vaccines Major Business
Table 15. CIMAB S.A Therapeutic Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. CIMAB S.A SWOT Analysis
Table 17. CIMAB S.A Therapeutic Vaccines Product and Services
Table 18. CIMAB S.A Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Agenus Basic Information, Manufacturing Base and Competitors
Table 20. Agenus Therapeutic Vaccines Major Business
Table 21. Agenus Therapeutic Vaccines Total Revenue (USD Million) (2017-2018)
Table 22. Agenus SWOT Analysis
Table 23. Agenus Therapeutic Vaccines Product and Services
Table 24. Agenus Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AVAX Technologies Basic Information, Manufacturing Base and Competitors
Table 26. AVAX Technologies Therapeutic Vaccines Major Business
Table 27. AVAX Technologies Therapeutic Vaccines Total Revenue (USD Million) (2017-2018)
Table 28. AVAX Technologies SWOT Analysis
Table 29. AVAX Technologies Therapeutic Vaccines Product and Services
Table 30. AVAX Technologies Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Vaccinogen Inc Basic Information, Manufacturing Base and Competitors
Table 32. Vaccinogen Inc Therapeutic Vaccines Major Business
Table 33. Vaccinogen Inc Therapeutic Vaccines Total Revenue (USD Million) (2017-2018)
Table 34. Vaccinogen Inc SWOT Analysis
Table 35. Vaccinogen Inc Therapeutic Vaccines Product and Services
Table 36. Vaccinogen Inc Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Corixa Basic Information, Manufacturing Base and Competitors
Table 38. Corixa Therapeutic Vaccines Major Business
Table 39. Corixa Therapeutic Vaccines Total Revenue (USD Million) (2017-2018)
Table 40. Corixa SWOT Analysis
Table 41. Corixa Therapeutic Vaccines Product and Services
Table 42. Corixa Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Dendreon Basic Information, Manufacturing Base and Competitors
Table 44. Dendreon Therapeutic Vaccines Major Business
Table 45. Dendreon Therapeutic Vaccines Total Revenue (USD Million) (2017-2018)
Table 46. Dendreon SWOT Analysis
Table 47. Dendreon Therapeutic Vaccines Product and Services
Table 48. Dendreon Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Therapeutic Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Therapeutic Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Therapeutic Vaccines Sales by Regions (2015-2020) (K Units)
Table 52. Global Therapeutic Vaccines Sales Market Share by Regions (2015-2020)
Table 53. Global Therapeutic Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Therapeutic Vaccines Sales by Countries (2015-2020) (K Units)
Table 55. North America Therapeutic Vaccines Sales Market Share by Countries (2015-2020)
Table 56. North America Therapeutic Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Therapeutic Vaccines Revenue Market Share by Countries (2015-2020)
Table 58. Europe Therapeutic Vaccines Sales by Countries (2015-2020) (K Units)
Table 59. Europe Therapeutic Vaccines Sales Market Share by Countries (2015-2020)
Table 60. Europe Therapeutic Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Therapeutic Vaccines Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Therapeutic Vaccines Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Therapeutic Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Therapeutic Vaccines Sales by Countries (2015-2020) (K Units)
Table 65. South America Therapeutic Vaccines Sales Market Share by Countries (2015-2020)
Table 66. South America Therapeutic Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Therapeutic Vaccines Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Therapeutic Vaccines Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Therapeutic Vaccines Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Therapeutic Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Countries (2015-2020)
Table 72. Global Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 73. Global Therapeutic Vaccines Sales Share by Type (2015-2020)
Table 74. Global Therapeutic Vaccines Revenue by Type (2015-2020) (USD Million)
Table 75. Global Therapeutic Vaccines Revenue Share by Type (2015-2020)
Table 76. Global Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 77. Global Therapeutic Vaccines Sales Share by Application (2015-2020)
Table 78. Global Therapeutic Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Therapeutic Vaccines Market Share Forecast by Regions (2021-2025)
Table 80. Global Therapeutic Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Therapeutic Vaccines Market Share Forecast by Type (2021-2025)
Table 82. Global Therapeutic Vaccines Sales Forecast by Application (2021-2025)
Table 83. Global Therapeutic Vaccines Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Therapeutic Vaccines Picture
Figure 2. Global Sales Market Share of Therapeutic Vaccines by Type in 2019
Figure 3. Peptide Therapeutic Vaccine Picture
Figure 4. Cell Therapeutic Vaccine Picture
Figure 5. Nucleic Acid Therapeutic Vaccine Picture
Figure 6. Therapeutic Vaccines Sales Market Share by Application in 2018
Figure 7. Oncotherapy Picture
Figure 8. Hepatitis B Picture
Figure 9. Tuberculosis Picture
Figure 10. Herpes Simplex Virus Picture
Figure 11. Others Picture
Figure 12. Global Therapeutic Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Therapeutic Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Therapeutic Vaccines Sales Market Share by Manufacturer in 2019
Figure 33. Global Therapeutic Vaccines Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Therapeutic Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Therapeutic Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Therapeutic Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Therapeutic Vaccines Revenue Market Share by Regions (2015-2020)
Figure 40. Global Therapeutic Vaccines Revenue Market Share by Regions in 2018
Figure 41. North America Therapeutic Vaccines Sales and Growth Rate (2015-2020)
Figure 42. Europe Therapeutic Vaccines Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Therapeutic Vaccines Sales and Growth Rate (2015-2020)
Figure 44. South America Therapeutic Vaccines Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Therapeutic Vaccines Sales and Growth Rate (2015-2020)
Figure 46. North America Therapeutic Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Therapeutic Vaccines Sales Market Share by Countries (2015-2020)
Figure 48. North America Therapeutic Vaccines Sales Market Share by Countries in 2018
Figure 49. North America Therapeutic Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Therapeutic Vaccines Revenue Market Share by Countries in 2018
Figure 51. United States Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Therapeutic Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Therapeutic Vaccines Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Therapeutic Vaccines Revenue Market Share by Countries in 2019
Figure 57. Germany Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Therapeutic Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Therapeutic Vaccines Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Therapeutic Vaccines Revenue Market Share by Regions 2019
Figure 65. China Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Therapeutic Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Therapeutic Vaccines Sales Market Share by Countries in 2019
Figure 72. South America Therapeutic Vaccines Revenue Market Share by Countries in 2019
Figure 73. Brazil Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Therapeutic Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Therapeutic Vaccines Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Therapeutic Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Therapeutic Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Therapeutic Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Therapeutic Vaccines Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Therapeutic Vaccines Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Therapeutic Vaccines Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Therapeutic Vaccines Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Therapeutic Vaccines Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
がん治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Therapeutic Cancer Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…- ウジ治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Maggot Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Maggot Therapeutic market …
- ピーナッツアレルギーワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peanut Allergy Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peanut Allergy Vaccine…
- 治療用カテーテルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Therapeutic Catheters market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 抗凝固治療薬モニタリングアッセイキットの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anticoagulant Therapeutic Drug Monitoring Assay Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…